Scanned by

    Norton

    Norton™ Safe Web

    Actinogen Clinical Trials Science Forum

    Actinogen Clinical Trials Science Forum

    01:37:38 |
    Download Here

    You Might Also Like:

    XanaCIDD Topline Results Webinar Recording

    XanaCIDD Topline Results Webinar Recording

    57:18 |
    Dr. Steve Gourlay, MD & CEO of Actinogen (ASX:ACW), at the PSR Life Science Conference 2024

    Dr. Steve Gourlay, MD & CEO of Actinogen (ASX:ACW), at the PSR Life Science Conference 2024

    20:17 |
    Actinogen Medical (ASX:ACW): Interview with CEO Dr Steve Gourlay

    Actinogen Medical (ASX:ACW): Interview with CEO Dr Steve Gourlay

    19:35 |
    ACW updated Depression Trial Results and implications

    ACW updated Depression Trial Results and implications

    57:00 |
    Wrap up - Australian Dementia Research Forum 2024 from Dr Jack Taylor

    Wrap up - Australian Dementia Research Forum 2024 from Dr Jack Taylor

    1:10 |
    Actinogen Medical – executive interview

    Actinogen Medical – executive interview

    14:46 |
    Actinogen Clinical Trials Science Forum 2024 – Pipeline in a Pill

    Actinogen Clinical Trials Science Forum 2024 – Pipeline in a Pill

    1:02:12 |
    ASX Small and Mid-Cap Conference March 2024 | Actinogen Medical Ltd (ASX:ACW)

    ASX Small and Mid-Cap Conference March 2024 | Actinogen Medical Ltd (ASX:ACW)

    20:24 |
    ACW $11. 1m Capital Raising

    ACW $11. 1m Capital Raising

    28:04 |
    ACW CMO Dr Dana Hilt presents at Sachs Neuroscience Forum

    ACW CMO Dr Dana Hilt presents at Sachs Neuroscience Forum

    14:12 |
    Actinogen Medical: Focussed on the treatment of Alzheimer’s disease

    Actinogen Medical: Focussed on the treatment of Alzheimer’s disease

    6:00 |
    ACW Australian Dementia Research Forum poster presentation

    ACW Australian Dementia Research Forum poster presentation

    3:30 |
    Actinogen Medical: Completion of Interim Analysis, capital raise of $15m and launch of SPP

    Actinogen Medical: Completion of Interim Analysis, capital raise of $15m and launch of SPP

    1:08 |
    Actinogen Medical: Developing Xanamem as a promising new therapy for Alzheimer’s disease

    Actinogen Medical: Developing Xanamem as a promising new therapy for Alzheimer’s disease

    3:52 |
    Actinogen Medical: XanADu, Xanamem & Cortisol: Oct 2018 Barcelona

    Actinogen Medical: XanADu, Xanamem & Cortisol: Oct 2018 Barcelona

    5:28 |
    Actinogen Medical Xanamem drug for Alzheimer's dementia

    Actinogen Medical Xanamem drug for Alzheimer's dementia

    4:53 |
    Actinogen Medical: Taking a new approach to the treatment of Alzheimer’s disease

    Actinogen Medical: Taking a new approach to the treatment of Alzheimer’s disease

    2:28 |
    Actinogen webcast positive Alzheimer’s Disease clinical results

    Actinogen webcast positive Alzheimer’s Disease clinical results

    52:42 |
    Actinogen Medical with Proactive at ASX Small and Mid Cap Conference

    Actinogen Medical with Proactive at ASX Small and Mid Cap Conference

    4:57 |
    Actinogen Medical: Managing Director's Address to Shareholders at AGM 25 Nov 2019

    Actinogen Medical: Managing Director's Address to Shareholders at AGM 25 Nov 2019

    26:26 |